← All comparisons
Head-to-head · FAERS comparison

Prednisone vs Sarilumab: side effects in FDA adverse event reports

How to read this page. FAERS report counts have no denominator; the comparison is of reporting patterns, not of risk. Signals are screened against each FDA label (badges) but not causally assessed. Not medical advice.

At a glance

PrednisoneSarilumab
Drug classCorticosteroidInterleukin-6 Receptor Antagonist
Brand names–Kevzara
FAERS reports499,79426,254
Serious79%42%
Death outcome52,1532,540
Boxed warningNoYes RISK OF SERIOUS INFECTIONS Patients treated with KEVZARA are at increased risk for developing serious infections that may lead to hospitalization or death [see

Signals both drugs share

ReactionPrednisoneSarilumabLabel screen (A / B)
Duodenal ulcer perforation4,860 · PRR 82.32,153 · PRR 332.7Labeled (related wording) / Labeled — boxed warning
Pemphigus9,174 · PRR 119.72,812 · PRR 234.0Likely indication confounding / Not in label — unassessed
Synovitis8,900 · PRR 40.32,674 · PRR 139.0Likely indication confounding / Not in label — unassessed
Glossodynia8,626 · PRR 25.92,711 · PRR 110.2Not in label — unassessed / Not in label — unassessed
Hand deformity7,949 · PRR 64.72,745 · PRR 212.5Not in label — unassessed / Not in label — unassessed
Pericarditis6,736 · PRR 28.02,683 · PRR 153.4Not in label — unassessed / Not in label — unassessed
Helicobacter infection5,030 · PRR 40.42,051 · PRR 201.5Not in label — unassessed / Not in label — unassessed
Folliculitis4,563 · PRR 32.71,448 · PRR 130.3Not in label — unassessed / Not in label — unassessed
Muscle injury4,043 · PRR 40.21,327 · PRR 154.2Not in label — unassessed / Not in label — unassessed
Rheumatic fever3,108 · PRR 104.31,503 · PRR 421.1Likely indication confounding / Likely indication confounding
Sleep disorder due to general medical condition, insomnia type3,038 · PRR 37.0859 · PRR 123.0Not in label — unassessed / Not in label — unassessed
Facet joint syndrome1,801 · PRR 55.5867 · PRR 303.9Not in label — unassessed / Not in label — unassessed
Peripheral venous disease1,457 · PRR 23.7693 · PRR 167.9Not in label — unassessed / Likely indication confounding
Deep vein thrombosis postoperative1,287 · PRR 80.1662 · PRR 408.9Not in label — unassessed / Not in label — unassessed
Dislocation of vertebra1,083 · PRR 39.3556 · PRR 266.8Not in label — unassessed / Not in label — unassessed
Adjustment disorder with depressed mood1,072 · PRR 47.2541 · PRR 293.8Not in label — unassessed / Not in label — unassessed
Bone erosion1,189 · PRR 20.8400 · PRR 101.6Not in label — unassessed / Not in label — unassessed
Lupus vulgaris814 · PRR 91.1454 · PRR 495.6Not in label — unassessed / Not in label — unassessed
Retinitis721 · PRR 31.4356 · PRR 216.8Likely indication confounding / Not in label — unassessed

Labeled signals distinctive to Prednisone

Labeled signals distinctive to Sarilumab

Common questions

Which has more reported side effects, Prednisone or Sarilumab?

Prednisone has 499,794 FAERS reports and Sarilumab 26,254. More reports does not mean more dangerous: volume follows how widely and how long a drug has been used, prescription vs over-the-counter status, and publicity. The seriousness share (79% vs 42%) is a better like-for-like signal of the kind of problems reported.

Which side effects do Prednisone and Sarilumab share?

Both drugs carry disproportionality signals for duodenal ulcer perforation, pemphigus, synovitis, glossodynia, hand deformity. Shared signals often reflect a shared drug class or the condition both are used for.

Is Prednisone or Sarilumab safer?

FAERS cannot answer that: it has no denominator and no comparator. Use this page to see which risks are already on each label and which signals are unlabeled, then check the prescribing information and your clinician for your situation.

Sources: openFDA FAERS pair statistics (OpenPV build 2026-09-14), FDA labels via openFDA, openFDA count queries for seriousness and deaths. Pair chosen because it is a commonly searched comparison. Generated 2026-10-08.